Hong-Min Liu

A comprehensive review of the mechanism and application prospect of PARP dual-target inhibitors in tumor treatment.

Although the inhibitors targeting PARP are successfully applied in the clinical treatment of tumors, the further application of PARP inhibitors is limited by reasons such as multi-drug resistance, the DNA replication fork function recovery and relatively low proportion of BRCA1/2-mutant tumors. There have been relevant...